Homing receptors as functional markers for classification, prognosis, and therapy of leukemias and lymphomas.
D000818:Animals; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm / Q000032:analysis* / Q000276:immunology / Q000502:physiology; D001402:B-Lymphocytes / Q000473:pathology; D001853:Bone Marrow / Q000473:pathology; D002448:Cell Adhesion; D002460:Cell Line; D004195:Disease Models, Animal; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006689:Hodgkin Disease; D006801:Humans; D007938:Leukemia / Q000145:classification / Q000473:pathology / Q000628:therapy; D007945:Leukemia, Lymphoid; D008099:Liver / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008208:Lymphatic System / Q000473:pathology; D008223:Lymphoma / Q000145:classification / Q000473:pathology / Q000628:therapy; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D011379:Prognosis; D011946:Receptors, Antigen / Q000032:analysis* / Q000276:immunology / Q000502:physiology; D013154:Spleen / Q000473:pathology; D013601:T-Lymphocytes / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D011946:Receptors, Antigen